Backing founders who rewrite the rules.

Cura Ventures
01 · Story +
Emna
LinkedIn

The Angel Thread.

I was born into a family of doctors. Healing wasn't a career choice in my house, it was the language we spoke at the table.

Improving people's lives became the thread running through everything since: years spent in hospital practice at Hôtel-Dieu, then inside the pharmaceutical industry, Servier, Pierre Fabre, UPSA, turning regulatory strategy into a real lever for patient access worldwide.

But it never moved fast enough. That impatience is what pushed my curiosity toward angel investing. It found me almost by accident, and I got hooked instantly: inspiring, challenging ideas and fast.

Today I invest full-time, across health and deeptech, backing bold, genuine founders who don't just meet the standard, they rewrite it. A space where possibility feels limitless, all in service of the same mission, just at a different scale.

02 · Thesis +

Investing where science creates a durable edge.

One north star: find founders where deep science or technical expertise creates a durable competitive advantage.

01 · Stage

Pre-Seed & Seed

Entering earliest, when risk is highest and founders need more than capital. They need a partner who speaks science, strategy, and the language of investors who will follow.

02 · Sectors

Healthcare & Deeptech

Digital health, medtech, biotech, diagnostics, AI in medicine. Investing where scientific depth creates defensible moats, not where trends create noise.

03 · Edge

Scientific Due Diligence

A doctorate in pharmacy and years in the industry make it possible to evaluate the science, not just the story. Reading the data, questioning the mechanism, and helping founders anticipate what regulators and co-investors will ask.

Geography  EU & US   ·   Decision  Fast & Direct

03 · Portfolio +

Bold ideas, exceptional founders.

The common thread is always a team with an edge.

Digital Health · Wellness
OneLeaf Health
Self-hypnosis app for smoking cessation, sleep & anxiety, $5.1M raised, backed by Frst & Kima
Active · 2022
Biotech · Deeptech
Spore Bio
AI + biophotonics for instant pathogen detection in food & pharma. €22M Series A (Singular). Google.org grantee.
Active · 2024
Healthcare · Infrastructure
Collectif Galien
Replicable infrastructure to create and operate health centers (maisons de santé) across France. Backed by Founders Future, Kima Ventures.
Active · 2024
AI · 3D Animation
Kinetix
Foundational AI for human motion, video-to-3D animation. Integrated into Adobe Mixamo & Unity Muse.
Active · 2024
HealthTech · AI
Uncovr
AI + surgical video for automated OR procedure coding and operative note generation
Active · 2025
Deeptech · Biotech
Tera
Nature's Lab, unlocking nature's chemistry. Stealth synthetic biology startup building next-gen biomanufacturing.
Active · 2025
Deeptech · Robotics
Scenix
Hybrid simulation for robotics, captures real-world physics to train robots at scale
Active · 2025
AI · PropTech
Davis AI
French AI generating architect-grade real estate designs. Gaudi-1 model. €4.6M (Heartcore, Balderton).
Active · 2025
Healthcare · AI Agents
Granit AI
AI agents automating admin tasks for health practices (dental, optical, EHPAD, pharmacy, labs), claims processing, billing, reconciliation. Live in 48h, 50+ centers equipped. Made in France.
Active · 2026
AI · Foundation Models
AMI Labs
Yann LeCun's world model startup, building AI that understands the physical world. $1.03B raised, $3.5B valuation.
Active · 2026
04 · Convictions +

A few things I believe deeply.

  • Science-first

    Every investment starts with the biology, the chemistry, the data. If the mechanism does not hold, nothing else matters.

  • Founder-centric

    Markets shift. Technology evolves. What does not change is the quality of the people building. I bet on exceptional founders.

  • Long-term horizon

    Healthcare does not move fast. Real innovation takes time, conviction, and patience. I am here for the long game.

  • Additive capital

    My value is not the cheque. It is the scientific expertise, the network, and the questions that make companies stronger.

05 · Contact +

Building something that matters? Let's talk.

Whether you're a founder at the very beginning, idea, no deck, no round open yet, or a fellow investor or scientist who wants to connect: this is the right door.